Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
It is commonplace for patients with Acute Lung Injury (ALI) to be injected with a dye, known as contrast material, before undergoing a CT (computerized tomography) scan of their lungs. Contrast ...
Medically reviewed by Rony Kampalath, MD CT scans and MRIs are imaging procedures that help healthcare providers see inside your body.CT scans are generally faster, less expensive, and more widely ...
The contrast media injectors market shall expand at a CAGR of 4.9% through 2030, but gains in 2020 will be impacted by the sluggishness induced by COVID-19. Future Market Insights, in its new study, ...
Medically reviewed by Daniel More, MD A contrast dye allergic reaction can occur after a diagnostic imaging test, such as magnetic resonance imaging (MRI) or computed tomography (CT) scan. The ...
Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...